Outbreak of West Nile virus causing severe neurological involvement in children, Nuba Mountains, Sudan, 2002. by Depoortere, E et al.
Outbreak of West Nile virus causing severe neurological
involvement in children, Nuba Mountains, Sudan, 2002
Evelyn Depoortere
1, Justine Kavle
1, Kees Keus
2, Herve ´ Zeller
3,S e ´verine Murri
3 and Dominique Legros
1
1 Epicentre, Paris, France
2 Me ´decins Sans Frontie `res, Amsterdam, The Netherlands
3 Institut Pasteur, Lyon, France
Summary An atypical outbreak of West Nile virus (WNV) occurred in Ngorban County, South Kordophan, Sudan,
from May to August 2002. We investigated the epidemic and conducted a case–control study in the
village of Limon. Blood samples were obtained for cases and controls. Patients with obvious sequelae
underwent cerebrospinal ﬂuid (CSF) sampling as well. We used enzyme-linked immunosorbent assay
(ELISA) and neutralization tests for laboratory diagnosis and identiﬁed 31 cases with encephalitis, four
of whom died. Median age was 36 months. Bivariate analysis did not reveal any signiﬁcant association
with the risk factors investigated. Laboratory analysis conﬁrmed presence of IgM antibodies caused by
WNV in eight of 13 cases, indicative of recent viral infection. The unique aspects of the WNW outbreak
in Sudan, i.e. disease occurrence solely among children and the clinical domination of encephalitis,
involving severe neurological sequelae, demonstrate the continuing evolution of WNV virulence. The
spread of such a virus to other countries or continents cannot be excluded.
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Introduction
West Nile virus (WNV), ﬁrst isolated in 1937 in Uganda, is
partofthefamilyofFlaviviridae,genusFlavivirus(Campbell
et al. 2002). The virus belongs to the Japanese encephalitis
serocomplex, which includes other viruses causing human
encephalitis, such as Japanese encephalitis, Murray Valley
encephalitis and St Louis encephalitis. Two lineages of WN
strainshavebeenidentiﬁed:virusesfromlineageIcausedthe
main recent epidemics with human encephalitis and are
distributed worldwide (Africa, India, Europe, Asia, the
Middle East, North America), while viruses from lineage II
have been identiﬁed only in Sub-Saharan Africa (McLean
et al. 2002). The virus is maintained in a cycle of wild birds
and mosquitoes, especially Culex species. Humans are
infected through mosquito bites (Berthet et al. 1997).
The disease’s clinical presentation has changed since the
mid-1990s (Campbell et al. 2002). Earlier, WNV epidem-
ics were mainly, although not exclusively, characterized by
cases of fever, accompanied by rash and lymphadenopathy
(Marberg et al. 1956; Hayes 1989). In contrast, during
recent epidemics in Romania 1996 (Tsai et al. 1998),
Russia 1999 (Platonov et al. 2001), the United States
1999 (Anonymous (MMWR) 1999) and Israel 2000
(Chowers et al. 2001; Weinberger et al. 2001), encephalitis
has dominated the clinical presentation while rash or
lymphadenopathy have rarely been observed. Change in
the virus’ virulence, population age structure or back-
ground immunity may contribute to this transformation
(Huba ´lek 2001; Petersen & Marﬁn 2002). Although it has
been purported that all ages are equally susceptible to
infection with WNV, elderly persons (over 60 years) are at
greater risk of neurological complications and death
(Campbell et al. 2002; Solomon & Vaughn 2002).
The Nuba Mountains are situated in central-southern
Sudan. The area is rural, remote, and has no motorized
transport. The population consists primarily of subsistence
farmers but people may own various farm animals in their
living compound. Some cattle camps exist in the region. The
medical non-governmental organization Me ´decins Sans
Frontie `res(MSF)hasbeenbasedinLimon,NgorbanCounty,
since February 2002, to ensure permanent medical support
and emergency preparedness. Measles is endemic in the
region and according to MSF data, an epidemic peaking in
May and June 2002 took place at about 1 week walking
distance west from Limon (Western Jebels). The national
polio immunization days were held in May, June and July
2002 with an estimated coverage of 72%, 99%, and 95%
respectively (A Henekamp, MSF country manager, personal
communication). A meningitis epidemic commenced in
January 2002 and peaked inMarch and April. Patients were
successfullytreatedwithoilychloramphenicolintramuscular
Tropical Medicine and International Health
volume 9 no 6 pp 730–736 june 2004
730 ª 2004 Blackwell Publishing Ltd(IM). The ﬁrst cases of clinical encephalitis were reported at
the tail end of the meningitis epidemic.
Methods
Description of the outbreak
A retrospective ﬁeld investigation of the encephalitis cases
in Ngorban County in the Nuba Mountains took place
3 weeks after the last case was identiﬁed. Data were
collected through extensive in-depth interviews with the
medical team in Limon, and comprehensive revisions of
available patient medical ﬁles. For patients with missing
information or lacking written documentation on the
medical history, we relied on the recollection of the
medical team. We recorded age, village of origin, date of
onset of symptoms, date of admission and disease outcome
of all patients. The caretakers of 11 previously identiﬁed
cases were extensively interviewed on the patient’s clinical
history and related environmental factors. Each of these
patients underwent a thorough clinical examination. Based
on this compiled information, a ‘probable case’ was
deﬁned as any person present in Ngorban County, who had
an episode of fever, prolonged ﬁts and loss of consciousness
since 1 May 2002. We also drew a spot map of all known
cases as well as an epidemic curve of the outbreak. Attack
rates were calculated using population estimates per
village, based on population ﬁgures of the 2000 polio
vaccination campaign (Elnayer 2000).
Case–control study
To better understand the epidemic we conducted a
case–control study. Due to long distances between houses
and villages, the mountainous terrain, and the limited time
available, it was restricted to the village of Limon (2-h
walking radius from the centre of the village), where the
majority of cases resided. The study enrolled all cases from
Limon, as identiﬁed from the health centre’s records, and
using the case deﬁnition described above. For each case,
two age-group matched (£12 years) controls were ran-
domly selected from the population of Limon. Information
on medical history, nutritional habits, exposure to animals
and clinically ill children since the beginning of the rainy
season (corresponding to 1 May), was obtained via
questionnaires applied to the head of the household, at
home or at the health centre.
Laboratory analysis
Duplicate samples of venous blood and cerebrospinal ﬂuid
(CSF) were taken from cases with neurological sequelae
residing in Limon, and from one convalescent patient. For
all other convalescent cases, and for the controls included
in the case–control study, only blood samples were taken.
Samples were taken after the child’s caretaker had given
written informed consent. All samples were frozen at
)70  C for viral analysis.
We did enzyme-linked immunosorbent assays (ELISA)
to detect IgM and IgG antibodies in serum and CSF
samples (IgM antibodies are responsible for the early
immune response and indicate an early infection, whereas
IgG antibodies correspond to the secondary immune
response: Murgue et al. 2001). The analysis included
ﬂaviviruses West Nile, Dengue (four serotypes) and
Japanese Encephalitis, and alphavirus O’Nyong Nyong.
To conﬁrm the results, Plaque Reduction Neutralization
Tests (PRNT80) were performed with serial twofold
dilutions of serum samples starting at 1:20, using Vero
cells and the France 2000 WN strain (Murgue et al.
2001). PRNT80 titres of 80 and above strongly suggest
WNV infection.
Statistical analysis
Proportions were compared using chi-square test (Fisher
exact test for expected frequencies below 5) and medians
using Mann–Whitney test. To examine the risk associated
with exposures, we calculated bivariate odds ratios (OR)
with 95% conﬁdence intervals (CI) (Epi Info 6.04, CDC
Atlanta, GA, USA).
Results
Clinical presentation of cases
Based on the 11 patient interviews, it was concluded the
disease started with a sudden onset of high fever, followed
by convulsions within 24–72 h. Convulsions were several
to many times a day, and mostly generalized. They lasted
for several days, up to weeks, but seemed to diminish in
frequency and severity over time, tending to become more
focalized to one part of the body (e.g. eye, hand, leg). Loss
of consciousness or lack of responsiveness in between
convulsions was reported. No haemorrhagic features were
noted. A history of rash was recorded for two patients.
Severe neurological sequelae such as agitation, spastic
contractions or paralysis, limited or no response to pain, as
well as leg and neck stiffness were observed. The combi-
nation of aggressive antibiotic therapy (chloramphenicol,
ampicillin and/or gentamycin) and steroids led to clinical
improvement in only two of the nine patients for whom the
information was available. No recovery was observed with
antimalarial treatment.
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A total of 31 patients were withheld as probable cases. All
occurred in Ngorban County between 23 May and 6
August 2002, and involved children between 6 months and
12 years of age (median: 36 months); 80.6% (25 of 31)
were 5 years or younger. The sex ratio (M/F) was 1.1 (17
of 14). The attack rate was 1.8 per 1000 population under
15 years, higher among children aged 5 years or younger
(3.3 vs. 0.7, P < 0.001). Cases came from 10 villages up to
8 h walk away from Limon. The highest attack rate was
found in the village of Limon (6.0 per 1000 population
<15 years), followed by Saraf Jamus (3.4 per 1000
population <15 years) and Tangal (2.4 per 1000 popula-
tion <15 years). The remaining villages had attack rates
between 1.2 and 0.5 per 1000 population <15 years. Four
patients (12.9%) died, seven cases (22.6%) recovered, six
(19.3%) retained slight, and nine (29.0%), severe neuro-
logical sequelae. For ﬁve patients (16.1%), the ﬁnal
outcome was unknown. The epidemic curve showed a ﬁrst
peak in the week of 20 May, a second during the week of
17 June, and a third in the week of 29 July (Figure 1). The
ﬁrst and second peak correspond to cases mainly from
the western part of the County (Saraf Jamus, and Tangal,
Um Cerdiba and Kurchu), whereas the third peak is caused
by the cases in Limon.
Case–control study
Ten cases and 19 controls were enrolled in the case–control
study. The proportion of males was 40.0% for the cases
(four of 10) and 63.1% for the controls (12 of 19)
(P ¼ 0.42). Cases and controls had a median age of 18
(range: 6–84) and 36 months (range: 6–60) respectively
(P ¼ 0.12). A history of fever and ﬁts was conﬁrmed for all
cases, but for four the disordered consciousness could not
be validated and they were considered suspected cases.
All controls that stated having been sick since the begin-
ning of the rainy season (n ¼ 17) conﬁrmed a history of
fever, but none reported ﬁts or loss of consciousness.
All cases and all controls had been vaccinated for polio
during the last mass vaccination campaign. Cases and
controls did not differ either by history of measles
vaccination or meningitis in the past year, or contact with
sick children. Contact with sick persons was not identiﬁed
as a potential risk factor for encephalitis. No signiﬁcant
association could be shown for any of the other factors
investigated (Table 1).
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Figure 1 New encephalitis cases per week and per date of onset,
Nuba Mountains, Sudan, 2002.
Table 1 History of personal contact, nutritional intake and contact with animals
All cases (%)
(n ¼ 10)
Probable cases (%)
(n ¼ 6)
Controls (%)
(n ¼ 19) All cases (OR)
Probable
cases (OR)
Know child who had meningitis 2 (20.0) 1 (16.7) 3* (16.7) 1.2 (0.1–12.7) 1.0 (0.0–17.1)
Know a ‘case’ 1 (10.0) 1 (16.7) 2 (10.5) 0.9 (0.0–17.1) 1.7 (0.0–35.6)
Know child who had diarrhoea
or vomiting or cough
1 (10.0) 0 (0.0) 6 (31.6) 0.2 (0.0–2.8) 0.0 (0.0–3.0)
Breastfeeding 6 (60.0) 4 (66.7) 7 (36.8) 2.6 (0.4–17.1) 3.4 (0.4–38.0)
Intake of goat milk 3 (30.0) 1 (16.7) 5 (26.3) 1.2 (0.2–8.8) 0.6 (0.0–8.0)
Intake of cow milk 1 (10.0) 0 (0.0) 3 (15.8) 0.6 (0.0–8.6) 0.0 (0.0–8.7)
Intake of pork meat 8 (80.0) 4 (66.7) 13 (68.4) 1.8 (0.2–17.6) 0.9 (0.1–10.1)
Intake of chicken meat 6 (60.0) 5 (83.3) 18 (94.7) 0.1 (0.0–1.1) 0.3 (0.0–12.8)
Intake of goat meat 4 (40.0) 3 (50.0) 13 (68.4) 0.3 (0.0–2.0) 0.5 (0.0–4.2)
Intake of cow meat 2 (20.0) 2 (33.3) 10 (52.6) 0.2 (0.0–1.7) 0.4 (0.0–4.2)
Contact with goats 6 (60.0) 4 (66.7) 8 (42.1) 2.1 (0.3–13.3) 2.7 (0.3–29.8)
Contact with sheep 1 (11.1) 0 (0.0) 1 (5.3) 2.2 (0.0–98.9) 0.0 (0.0–81.2)
Contact with pigs 4 (44.4) 3 (60.0) 4 (21.0) 3.0 (0.4–24.3) 5.6 (0.5–80.5)
Contact with chicken 8 (80.0) 5 (83.3) 17 (89.5) 0.5 (0.0–6.0) 0.6 (0.0–20.8)
* n ¼ 18 (1 missing value);  n ¼ 9 (1 missing value);  n ¼ 5 (1 missing value).
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Blood samples of 30 children were examined: eight were
cases with neurological sequelae, ﬁve were convalescent
and 17 were controls. Samples of CSF were taken for seven
cases with neurological sequelae and for one convalescent.
ELISA results for Dengue serotypes 1, 2, 3 and 4, and
Japanese Encephalitis were negative, or slightly positive.
For the cases, positive results were found only for WNV
(Table 2). Seven of the eight children (87.5%) with
neurological sequelae were positive for blood IgM and
IgG of a ﬂavivirus of the group West Nile; the CSF was
IgM-positive for six of seven cases with neurological
sequelae. As for the convalescent cases, one blood sample
showed signs of recent infection, and all others were
negative for WNV, while the one CSF sample available
showed inconclusive results (borderline IgG and IgM)
(Table 2). Neutralization tests were done for six patients
with sequelae, for whom WNV PRNT80 titres ranged from
80 to >640. For the one recovered case, who had WNV IgM
but no IgG antibodies, a PRNT80 titre of 40 was found.
Thirteen of 17 controls (76.5%) were negative for WNV
infection, three (17.6%) showed signs of an old infection
which was conﬁrmed by PRNT80 (titres 40, 160 and 320).
Onepatient(5.9%)showedsignsofarecentinfectionwitha
ﬂavivirus of the group West Nile and had a PRNT80 titre of
80. IgG antibodies against the alphavirus O’Nyong Nyong
were detected in six controls (35.3%), but none of the cases.
Discussion
A WNV outbreak occurred in Ngorban County, in the
Nuba Mountains of Sudan. The outbreak involved 31
children aged up to 12 years and occurred during the
national polio immunization days. The epidemiological
curve showed three peaks: the magnitude of the ﬁrst two
peaks might be underestimated due to distances from the
health centre; the third peak might be overestimated
because of sensitization of the medical personnel.
A relationship between the epidemic and the concur-
rent polio vaccination campaign was unlikely, due to the
rare occurrence of post-vaccination incidents (one case/
1.4–4.1 million OPV doses administered), and the char-
acteristic clinical presentation of post-vaccination inci-
dents (i.e. acute-onset ﬂaccid paralysis), which was
absent in this subgroup of the population (Kohler et al.
2002). The case–control study suggested that the out-
break was no consequence or continuation of the
meningitis epidemic, which subsided in June. Neither a
history of meningitis, nor previous contacts with a
meningitis case were found to represent a risk for
encephalitis. This ﬁnding corresponded to the clear
distinction observed in the clinical presentation of cases,
as well as in their lack of response to antibiotic
treatment. The case–control study permitted to consider
as unlikely any person-to-person type of transmission,
including measles. No other conclusions could be drawn
from the case–control study, as the number of partici-
pants was small, and OR had wide CI.
The laboratory analysis, showing WNV IgM antibodies
in serum and CSF, and neutralizing antibodies in serum,
identiﬁed WNV as the most probable cause of this
outbreak. However, the close antigenic relation of the
Japanese encephalitis serocomplex viruses causes import-
ant serological cross-reactions (Hubale ´k & Halouzka
1999), possibly complicating diagnosis. Although the
serological results of the outbreak in the Nuba Mountains
were compelling, no irrefutable method such as virus
isolation was attempted. Recently in the United States,
WNV genome was detected in a CSF sample whereas
serology was negative (Huang et al. 2002).
The WNV antibodies were documented as early as 1956
in children aged up to 14 years in the same region of the
Nuba Mountains: In 23% in Kadugli, 68% in Um Dorein
and 29% in Talodi (Taylor et al. 1956). Data for older
ages were not reported. More recently, WNV antibodies
occurred in Northern Province (Watts et al. 1994) and
Khartoum (McCarthy et al. 1996). However, no epidemics
have been reported for the area, and information on the
mosquito species present in the Nuba Mountains was not
available.
Generally, in endemic countries children usually present
mild symptoms when infected with WNV, whereas a large
proportion of the adult population has neutralizing anti-
bodies (Murgue et al. 2002). During the latest epidemics,
neurologicalcomplicationswerepredominantlyobservedin
the elderly (>60 years). The clinical presentation of WN
virus infection observed in the Nuba outbreak corresponds
to the evolution of previous epidemics, with a progressive
increase of neurological involvement and encephalitis,
although neurological sequelae have not been described
(Huba ´lek 2001; Petersen & Marﬁn 2002). However, the
outbreak in the Nuba Mountains, to our knowledge, only
concernedchildren,themajorityofwhomwasundertheage
of 5. Similar ﬁndings have been observed in Algeria in 1994,
where serology was undergone for 18 clinically ill patients;
13 were children between 10 months and 9 years and one
was an adolescent of 14 years, all positive for WNV (Le
Guenno et al. 1996). In India, WNV was isolated from the
brains of three children who had died of encephalitis,
originating from two districts within the same state,
20 months apart (March 1980 and November/December
1981) (George et al. 1984). In contrast, in other recent
outbreaks, children with encephalitis were absent or
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mania), no children under 9 years of age were reported
among 393 patients with conﬁrmed WNV infection (Tsai
et al. 1998); during the 1999 outbreak in Volgograd
(Russia),<15%ofthepatientswerechildrenunder15 years,
whereas more than 50% of all cases were 50 years or older
(Platonov et al. 2001). In the USA, in 1999, among the 78
hospitalized patients with conﬁrmed WNV infection, there
wasonlyonechildof5 yearsandoneof15 yearsold(Horga
& Fine 2001). Of the 26 patients with neurological
involvement reported in a regional hospital during the
outbreak in Israel in 2000, ﬁve were children, all between 9
and 15 years (Klein et al. 2002).
No vaccine exists to prevent WNV infection in humans.
Vector control and health education on how to prevent
mosquito bites are the only preventive methods available.
Whereas WNV epidemics used to be sporadic and with
rare severe implications, the number of outbreaks reported
has exploded since the 1990s. The recent strains seem more
virulent with greater epidemic potential and spread to new
regions (Campbell et al. 2002; Gubler 2002). As history
has shown, new virus strains might be transported from
one region to another (Solomon & Cardosa 2000; Petersen
& Roehrig 2001). Whether this happens via migratory
birds, bird trade or international travel is not clear
(McGuigan 2002). An extended and internationally
coordinated surveillance system would help to better
understand the epidemiology and pathogenicity of West
Nile virus, and to contain the risk for these new epidemics.
Conclusion
The West Nile virus outbreak in the Nuba Mountains
affected only children and was characterized by serious
neurological involvement, both demonstrating the evolu-
tion of the virulence of WNV. The rapid change of viruses
increasingly challenges our current knowledge about
known diseases, as well as our preparedness for new
emerging diseases. It is not unlikely that similar outbreaks
in developing countries have passed unnoticed, due to lack
of investigative and diagnostic capacities. Recent events
have illustrated the ease of worldwide spread of such
viruses, and should serve as a lesson demanding an
organized response, increasing the efforts put on surveil-
lance and investigation, as well as monitoring possible
spread to other continents.
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